Crinetics Pharmaceuticals Return On Tangible Equity 2017-2024 | CRNX

Crinetics Pharmaceuticals return on tangible equity from 2017 to 2024. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.

Crinetics Pharmaceuticals Return On Tangible Equity 2017-2024 | CRNX

Crinetics Pharmaceuticals return on tangible equity from 2017 to 2024. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.